Purchase at Retail Pricing Join STEMTech & Save Money Contact STEMTech

CARDIOVASCULAR REVASCULARIZATION MEDICINE
  including Molecular Interventions
Posted January 1, 2008

  CLICK HERE TO DOWNLOAD THE SUMMARY   
    

Description

Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine.

Cardiovascular Revascularization Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological interventions, restenosis management, and prevention, including experiments conducted in human subjects, in laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, congenital heart disease, coronary heart disease, epidemiology, genetics, health services and outcomes research, invasive imaging, molecular cardiology, preventive cardiology, and vascular medicine.

Cardiovascular Revascularization Medicine will consider all articles describing clinical trials and translational research (ie, those that unite the clinic with the laboratory). The Journal publishes original articles, rapid communications, reviews, technical notes, teaching editorials, and special features. Original articles that address any aspect of cardiovascular revascularization medicine are invited. Letters to the Editor and interesting images are encouraged.

CLICK HERE TO DOWNLOAD THE SUMMARY.

©2010 STEMTech HealthSciences, Inc. All Rights Reserved.
We are proud members of the Direct Selling Association,. To view our Code of Ethics by which we abide, click here.